PatientsVille.com Logo

PatientsVille

Dilatrend Side Effects

Common Dilatrend Side Effects


The most commonly reported Dilatrend side effects (click to view or check a box to report):

Bradycardia (10)
Hypotension (8)
Dyspnoea (8)
Dizziness (6)
Cardiac Arrest (5)
Cardiac Failure (5)
Nausea (5)
Loss Of Consciousness (5)
Sinus Bradycardia (5)
Death (4)
Blood Creatinine Increased (4)
Difficulty In Walking (4)
Vertigo (4)
Muscular Weakness (4)
Oedema Peripheral (4)
Myocardial Infarction (4)
Rhabdomyolysis (3)
Transplant Rejection (3)
Wheezing (3)
Ventricular Tachycardia (3)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Dilatrend Side Effects Reported to FDA

The following Dilatrend reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Dilatrend on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Surgery
This is a report of a 82-year-old female patient (weight: NA) from VENEZUELA, suffering from the following symptoms/conditions: hypertension,hypercholesterolaemia, who was treated with Dilatrend (dosage: 6.25 Mg, 1x/day, start time: Jan 01, 2010), combined with:
  • Lipitor (10 Mg, 1x/day)
  • Telmisartan (40/12.5 Mg, 1x/day)
and developed a serious reaction and side effect(s). The consumer presented with:
  • Surgery
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Dilatrend treatment in female patients, resulting in surgery side effect.

Alanine Aminotransferase Increased, Upper Gastrointestinal Haemorrhage, Duodenal Ulcer, Haemoglobin Decreased, Aspartate Aminotransferase Increased, Red Blood Cell Count Decreased
This report suggests a potential Dilatrend Alanine Aminotransferase Increased, Upper Gastrointestinal Haemorrhage, Duodenal Ulcer, Haemoglobin Decreased, Aspartate Aminotransferase Increased, Red Blood Cell Count Decreased side effect(s) that can have serious consequences. A 53-year-old male patient (weight: NA) from KOREA, REPUBLIC OF was diagnosed with the following symptoms/conditions: hypertension and used Dilatrend (dosage: 25 Mg, Unk) starting Feb 17, 2011. Soon after starting Dilatrend the patient began experiencing various side effects, including:
  • Alanine Aminotransferase Increased
  • Upper Gastrointestinal Haemorrhage
  • Duodenal Ulcer
  • Haemoglobin Decreased
  • Aspartate Aminotransferase Increased
  • Red Blood Cell Count Decreased
Drugs used concurrently:
  • Neurontin
  • Adelavin (2 Ml, Unk)
  • Ceftriaxone (2 G, Unk)
  • Nexavar (200 Mg Am, 400 Mg Pm = 600 Mg)
  • Nexavar (400 Mg, Qd)
  • K40ns500 (500 Ml, Unk)
  • Lasix (20 Mg, Unk)
  • Lansoprazole (15 Ml, Unk)
The patient was hospitalized. Although Dilatrend demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as alanine aminotransferase increased, may still occur.

Fatigue, Headache, Hypertension, Malaise
This Fatigue, Headache, Hypertension, Malaise problem was reported by a consumer or non-health professional from GERMANY. A 85-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On Feb 12, 2011 this consumer started treatment with Dilatrend (dosage: NA). The following drugs were being taken at the same time:
  • Atacand Hct (8/12.5 Mg In The Morning)
  • Atacand
When commencing Dilatrend, the patient experienced the following unwanted symptoms/side effects:
  • Fatigue
  • Headache
  • Hypertension
  • Malaise
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as fatigue, may become evident only after a product is in use by the general population.

Tongue Neoplasm Benign
This is a report of a 45-year-old female patient (weight: NA) from AUSTRIA. The patient developed the following symptoms/conditions: NA and was treated with Dilatrend (dosage: Unk) starting Jan 01, 2001. Concurrently used drugs:
  • Thyrex (Unk)
  • Tresleen (50 Mg, 1x/day)
  • Blopress (Unk)
  • Mefenamic Acid (Unk)
Soon after that, the consumer experienced the following side effects:
  • Tongue Neoplasm Benign
This opens a possibility that Dilatrend treatment could cause the above reactions, including tongue neoplasm benign, and some female subjects may be more susceptible.


Hypothyroidism, Myxoedema
A 65-year-old male patient (weight: NA) from GREECE with the following symptoms/conditions: NA started Dilatrend treatment (dosage: NA) on Oct 01, 2009. Soon after starting Dilatrend treatment, the subject experienced various side effects, including:
  • Hypothyroidism
  • Myxoedema
Concurrently used drugs:
  • Sutent (50 Mg, 1x/day)
  • Salospir
  • Coaprovel
This finding indicates that some male patients could be more vulnerable to Dilatrend.

Cachexia, Hypertensive Crisis
A 83-year-old female patient from AUSTRIA (weight: NA) experienced symptoms, such as: NA and was treated with Dilatrend(dosage: NA). The treatment was initiated on May 07, 2010. After that a consumer reported the following side effect(s):
  • Cachexia
  • Hypertensive Crisis
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Dilatrend efficacy:
  • Acemin
  • Normoxin
  • Lovenox
  • Rocaltrol (1.5 Mcg Per Week)
  • Lovenox
  • Baypress
  • Zemplar
  • Zemplar
The patient was hospitalized.

Abdominal Pain, Nausea, Dysphagia, Pyrexia, Diarrhoea
In this report, Dilatrend was administered for the following condition: NA.A 83-year-old male consumer from GERMANY (weight: NA) started Dilatrend treatment (dosage: NA) on Nov 16, 2010.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Abdominal Pain
  • Nausea
  • Dysphagia
  • Pyrexia
  • Diarrhoea
A possible interaction with other drugs could have contributed to this reaction:
  • Enapren
  • Simvastatin (Simvastatin Sandoz)
  • Coumadin
  • Irinotecan Hcl (Irinotecan Hospira Inter On:30nov10)
  • Erbitux (Strength:5mg/ml Inter On:30nov10)
The patient was hospitalized.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Dilatrend treatment could be related to the listed above side effect(s).

Eyelid Oedema
This is a report of the following Dilatrend side effect(s):
  • Eyelid Oedema
A 63-year-old male patient from GREECE (weight: NA) presented with the following condition: NA and received a treatment with Dilatrend (dosage: NA) starting: Jan 01, 2009.The following concurrently used drugs could have generated interactions:
  • Hytrin (Unk (5mg))
  • T4
The patient was hospitalized.This report suggests that a Dilatrend treatment could be associated with the listed above side effect(s).

International Normalised Ratio Increased, Aphagia
This Dilatrend report was submitted by a 83-year-old female consumer from ITALY (weight: NA). The patient was diagnosed with: NA and Dilatrend was administered (dosage: NA) starting: Sep 16, 2007. The consumer developed a set of symptoms:
  • International Normalised Ratio Increased
  • Aphagia
Other drugs used simultaneously:
  • Cordarone
  • Aprovel
  • Coumadin (Interrupted:25jan2011)
  • Aliskiren Fumarate
  • Aspirin
Those unexpected symptoms could be linked to a Dilatrend treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Vomiting
This is a report of a possible correlation between Dilatrend use and the following symptoms/side effect(s):
  • Vomiting
which could contribute to an assessment of Dilatrend risk profile.A 74-year-old female consumer from ECUADOR (weight: NA) was suffering from hypertension and was treated with Dilatrend (dosage: Unk) starting Jan 01, 2011.Other concurrent medications:
  • Diovan (Unk)
  • Exelon (4.5 Mg, Qd)


Rash, Headache, Hypotension, Oxygen Saturation Decreased
A 60-year-old female patient from ITALY (weight: NA) presented with the following symptoms: NA and after a treatment with Dilatrend (dosage: NA) experienced the following side effect(s):
  • Rash
  • Headache
  • Hypotension
  • Oxygen Saturation Decreased
The treatment was started on Dec 03, 2010. Dilatrend was used in combination with the following drugs:
  • Tazocin (4.5 G, Unk)
  • Micardis
  • Aspirin
  • Lantus (24 Iu, Unk)
  • Novorapid (36 Iu, Unk)
  • Cardura
This report could alert potential Dilatrend consumers.


In this report, a 67-year-old male patient from AUSTRALIA (weight: NA) was affected by a possible Dilatrend side effect.The patient was diagnosed with NA. After a treatment with Dilatrend (dosage: 25mg Twice Per Day, start date: Jan 01, 1986), the patient experienced the following side effect(s):
    The following simultaneously used drugs could have led to this reaction: NA.The findings here stress that side effects should be taken into consideration when evaluating a Dilatrend treatment.

    Hypertensive Crisis
    This is a report of a 83-year-old female patient from AUSTRIA (weight: NA), who used Dilatrend (dosage: NA) for a treatment of NA. After starting a treatment on Mar 05, 2010, the patient experienced the following side effect(s):
    • Hypertensive Crisis
    The following drugs could possibly have interacted with the Dilatrend treatment
    • Loniten
    • Aspirin
    • Neorecormon
    • Zemplar
    • Blopress
    • Fragmin
    • Avelox
    • Ferrlecit
    The patient was hospitalized.Taken together, these observations suggest that a Dilatrend treatment could be related to side effect(s), such as Hypertensive Crisis.

    Syncope, Hypotension
    This syncope side effect was reported by a physician from ITALY. A 69-year-old male patient (weight:NA) experienced the following symptoms/conditions: NA. The patient was prescribed Dilatrend (dosage: NA), which was started on Oct 01, 2010. Concurrently used drugs:
    • Zaroxolyn
    • Lasix (Dose:4 Unit(s))
    • Iperten (Dose:1 Unit(s))
    • Apidra
    • Lantus
    • Karvea (Dose:1 Unit(s))
    • Torvast (Dose:1 Unit(s))
    When starting to take Dilatrend the consumer reported the following symptoms:
    • Syncope
    • Hypotension
    These side effects may potentially be related to Dilatrend.

    Hyperglycaemia
    This is a Dilatrend side effect report of a female patient (weight:NA) from TURKEY, suffering from the following symptoms/conditions: NA, who was treated with Dilatrend (dosage:NA, start time: Nov 21, 2007), combined with:
    • Norvasc
    • Sandostatin Lar
    • Afinitor (10 Mg, Qd)
    , and developed a serious reaction and a hyperglycaemia side effect. The patient presented with:
    • Hyperglycaemia
    which developed after the beginning of treatment. The patient was hospitalized. This side effect report can indicate a possible existence of increased vulnerability to Dilatrend treatment in female patients suffering from NA, resulting in hyperglycaemia.

    Oedema Peripheral, Overdose, Respiratory Distress
    This report suggests a potential Dilatrend oedema peripheral side effect(s) that can have serious consequences. A 70-year-old female patient from GERMANY (weight:NA) was diagnosed with the following health condition(s): hypertension and used Dilatrend (dosage: 50mg Twice Per Day) starting NS. Soon after starting Dilatrend the patient began experiencing various side effects, including:
    • Oedema Peripheral
    • Overdose
    • Respiratory Distress
    Drugs used concurrently:NA. Although Dilatrend demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as oedema peripheral, may still occur.

    Dehydration, Hypotension
    This dehydration problem was reported by a consumer or non-health professional from SWITZERLAND. A 81-year-old female patient (weight: NA) was diagnosed with the following medical condition(s): NA.On May 01, 2010 a consumer started treatment with Dilatrend (dosage: NA). The following drugs/medications were being taken at the same time:
    • Diovan Hct
    • Mirtazapine
    • Pantozol
    • Sintrom
    When commencing Dilatrend, the patient experienced the following unwanted symptoms /side effects:
    • Dehydration
    • Hypotension
    The patient was hospitalized. Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as dehydration, may become evident only after a product is in use by the general population.


    This is a Dilatrend side effect report of a 80-year-old female patient (weight: NA) from AUSTRALIA. The patient developed the following symptoms/conditions: cardiac failure congestive and was treated with Dilatrend (dosage: NA) starting NS. Concurrently used drugs: NA. Soon after that, the consumer experienced the following of symptoms:
      This opens a possibility that Dilatrend could cause death and that some female patients may be more susceptible.

      Transplant Rejection
      A 35-year-old male patient (weight: NA) from KOREA, REPUBLIC OF with the following symptoms: NA started Dilatrend treatment (dosage: NA) on Nov 14, 2008. Soon after starting Dilatrend treatment, the consumer experienced several side effects, including:
      • Transplant Rejection
      . Concurrently used drugs:
      • Cellcept (250mg Twice Per Day)
      • Benzbromarone
      • Atorvastatin Calcium
      • Tenormin
      • Ursodiol
      • Methylprednisolone
      • Amosartan
      The patient was hospitalized. This finding indicates that some patients can be more vulnerable to developing Dilatrend side effects, such as transplant rejection.

      Oedema Peripheral, Overdose, Respiratory Distress
      This oedema peripheral side effect was reported by a physician from GERMANY. A 70-year-old female patient (weight:NA) experienced the following symptoms/conditions: hypertension.The patient was prescribed Dilatrend (dosage: 50mg Twice Per Day), which was started on NS. Concurrently used drugs: NA..When starting to take Dilatrend the consumer reported symptoms, such as:
      • Oedema Peripheral
      • Overdose
      • Respiratory Distress
      These side effects may potentially be related to Dilatrend.

      Transplant Rejection
      This is a report of a 35-year-old male patient (weight: NA) from UNITED STATES, suffering from the following symptoms/conditions: NA, who was treated with Dilatrend (dosage: NA, start time: Jan 17, 2009), combined with:
      • Benzbromarone
      • Atorvastatin Calcium
      • Tenormin
      • Ursodiol
      • Methylprednisolone
      • Methylprednisolone
      • Amosartan (Other Indication: Proteinuria)
      • Cellcept
      and developed a serious reaction and side effect(s). The consumer presented with:
      • Transplant Rejection
      which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Dilatrend treatment in male patients, resulting in transplant rejection side effect. The patient was hospitalized.

      Myocardial Infarction
      This report suggests a potential Dilatrend Myocardial Infarction side effect(s) that can have serious consequences. A 82-year-old female patient (weight: NA) from AUSTRALIA was diagnosed with the following symptoms/conditions: NA and used Dilatrend (dosage: NA) starting NS. Soon after starting Dilatrend the patient began experiencing various side effects, including:
      • Myocardial Infarction
      Drugs used concurrently: NA. Although Dilatrend demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as myocardial infarction, may still occur.

      Myocardial Infarction
      This Myocardial Infarction problem was reported by a physician from AUSTRALIA. A 82-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On NS this consumer started treatment with Dilatrend (dosage: NA). The following drugs were being taken at the same time: NA. When commencing Dilatrend, the patient experienced the following unwanted symptoms/side effects:
      • Myocardial Infarction
      Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as myocardial infarction, may become evident only after a product is in use by the general population.

      Hypoglycaemia, Loss Of Consciousness
      This is a report of a 74-year-old female patient (weight: NA) from SWITZERLAND. The patient developed the following symptoms/conditions: NA and was treated with Dilatrend (dosage: 6.25mg Twice Per Day) starting NS. Concurrently used drugs:
      • Humalog
      • Levemir
      • Aspirin
      • Enapren
      • Moduretic 5-50
      • Nitroderm
      • Fosamax
      • Euthyrox
      Soon after that, the consumer experienced the following side effects:
      • Hypoglycaemia
      • Loss Of Consciousness
      The patient was hospitalized. This opens a possibility that Dilatrend treatment could cause the above reactions, including hypoglycaemia, and some female subjects may be more susceptible.

      Transplant Rejection
      A 35-year-old male patient (weight: NA) from KOREA, REPUBLIC OF with the following symptoms/conditions: NA started Dilatrend treatment (dosage: NA) on Nov 14, 2008. Soon after starting Dilatrend treatment, the subject experienced various side effects, including:
      • Transplant Rejection
      Concurrently used drugs:
      • Cellcept (250mg Twice Per Day)
      • Benzbromarone
      • Atorvastatin Calcium
      • Tenormin
      • Ursodiol
      • Methylprednisolone
      This finding indicates that some male patients could be more vulnerable to Dilatrend.

      1 of 5 



      Keep Track of Side Effects

      Note Your Observations

      It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

      Why Your Notes are Important

      Your notes could be helpful in several ways:

    • You can use them to remind you of details that may alert your health care professional(s) to a problem
    • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

    • Log Form

      You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

      Medicine Name and Dosage:
      Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
      Scale: 1 = very mild to 10 = very bad

      You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


      Discuss Dilatrend Side Effects

      Did You Have a Dilatrend Side Effect?

      Yes, Severe
      Yes, Moderate
      Yes, Minor
      No

      How Effective is Dilatrend for You?

      Exceeded Expectations
      Effective
      Somewhat Effective
      Not Effective

      Dilatrend Safety Alerts, Active Ingredients, Usage Information

      More About Dilatrend

      Side Effects reported to FDA: 103

      Dilatrend safety alerts: No

      Reported deaths: 19

      Reported hospitalizations: 55

      Latest Dilatrend clinical trials